Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

Ronald de Wit, R Sylvester, C Tsitsa, PHM de Mulder, DT Sleyfer, WW ten Bokkel Huinink, SB Kaye, AT van Oosterom, Eva Boven, K Vermeylen, Gerrit Stoter

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)432-435
Number of pages4
JournalBritish Journal of Cancer
Volume75
Publication statusPublished - 1997

Cite this